Lutetium Lu 177 vipivotide tetraxetan is under clinical development by Advanced Accelerator Applications and currently in Phase III for Metastatic Prostate Cancer. According to GlobalData, Phase III ...

Lutetium Lu 177 vipivotide tetraxetan is under clinical development by Advanced Accelerator Applications and currently in Phase II for Castration-Resistant Prostate Cancer (CRPC). According to ...

TAIPEI -- China is increasing its scrutiny of exports by Apple and other American tech companies, hampering their efforts to expand production in Southeast Asia and India, according to multiple ...

This detector registered their implantation as well as their subsequent decay. In total, 27 atoms of Rf-252 decaying by fission with a half-life of 13 microseconds were detected. Thanks to the ...

Kevin O'Marah, the chief research officer and co-founder of Zero100, a community research platform working towards zero carbon, sheds more light on how supply chains are likely to be impacted by ...

"While individual building blocks to power decentralized AI on the blockchain are available, they are mostly fragmented across platforms and chains," said Han Jin, CEO at Bluwhale. "Our L3 in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...